Clinical Trials Logo

Vulvar Cancers clinical trials

View clinical trials related to Vulvar Cancers.

Filter by:
  • None
  • Page 1

NCT ID: NCT01047345 Completed - Genital Warts Clinical Trials

A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASILâ„¢ (V503-006)

Start date: February 24, 2010
Phase: Phase 3
Study type: Interventional

This study will evaluate whether V503 (9vHPV vaccine), is well tolerated in girls and women between 12 and 26 years old who have previously been vaccinated with GARDASILâ„¢. Participants will receive vaccination with 9vHPV vaccine or placebo on Day 1, Month 2, and Month 6 of the Base Study. Participants who receive placebo in the Base Study will be eligible to receive vaccination with 9vHPV vaccine on Day 1, Month 2, and Month 6 of the Extension Study.